Q4 2024 EPS Estimates for Alto Ingredients, Inc. (NASDAQ:ALTO) Boosted by HC Wainwright

Alto Ingredients, Inc. (NASDAQ:ALTO - Free Report) - HC Wainwright boosted their Q4 2024 earnings estimates for shares of Alto Ingredients in a research report issued to clients and investors on Tuesday, May 7th. HC Wainwright analyst A. Dayal now forecasts that the company will post earnings per share of $0.10 for the quarter, up from their previous forecast of $0.06. HC Wainwright currently has a "Buy" rating and a $5.50 target price on the stock. The consensus estimate for Alto Ingredients' current full-year earnings is ($0.26) per share. HC Wainwright also issued estimates for Alto Ingredients' FY2025 earnings at $0.22 EPS.

Alto Ingredients Stock Performance

Shares of NASDAQ:ALTO traded down $0.04 during mid-day trading on Wednesday, reaching $1.72. 1,035,021 shares of the company traded hands, compared to its average volume of 640,524. Alto Ingredients has a 52 week low of $1.53 and a 52 week high of $4.98. The firm has a market cap of $130.20 million, a PE ratio of -4.51 and a beta of 1.92. The company's 50 day moving average price is $2.04 and its 200-day moving average price is $2.37. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.59 and a quick ratio of 1.78.

Alto Ingredients (NASDAQ:ALTO - Get Free Report) last released its quarterly earnings results on Monday, May 6th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.01. Alto Ingredients had a negative return on equity of 7.32% and a negative net margin of 2.29%. The business had revenue of $240.63 million during the quarter, compared to analyst estimates of $199.56 million. During the same quarter in the previous year, the company posted ($0.17) earnings per share.

Institutional Trading of Alto Ingredients

A number of hedge funds and other institutional investors have recently modified their holdings of ALTO. Barclays PLC boosted its stake in Alto Ingredients by 210.5% in the 3rd quarter. Barclays PLC now owns 106,345 shares of the company's stock worth $471,000 after purchasing an additional 72,092 shares during the period. Charles Schwab Investment Management Inc. grew its stake in Alto Ingredients by 11.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,080,916 shares of the company's stock valued at $9,198,000 after acquiring an additional 210,420 shares in the last quarter. Citigroup Inc. grew its stake in Alto Ingredients by 78,289.3% during the third quarter. Citigroup Inc. now owns 87,796 shares of the company's stock valued at $388,000 after acquiring an additional 87,684 shares in the last quarter. Acadian Asset Management LLC bought a new stake in Alto Ingredients in the 3rd quarter valued at $618,000. Finally, Kennedy Capital Management LLC purchased a new stake in Alto Ingredients in the 3rd quarter worth $147,000. 42.44% of the stock is owned by hedge funds and other institutional investors.

About Alto Ingredients

Alto Ingredients, Inc produces, distributes, and markets specialty alcohols, renewable fuel, and essential ingredients in the United States. The company operates in three segments: Marketing and Distribution, Pekin Campus Production, and Western Production. It offers specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and cleaners for health, home, and beauty markets; grain neutral spirits used in alcoholic beverages and vinegar, as well as corn germ used in corn oils in the food and beverage markets; alcohols and other products for paint applications and fertilizers in the industrial and agriculture markets; and essential ingredients include dried yeast, corn protein meal, corn protein feed, distiller's grains, and liquid feed for commercial animal feed and pet food applications, as well as yeast for human consumption.